Arkolith/Insider Trading/LTRN/Form 4

Cavu Advisors, LLC

10% OwnerLantern Pharma Inc. (LTRN) · full profile →Form 4 · filed Jun 13, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$208K
Net Open-Market Flow
-$208K
Transactions
15
15 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 12, 2025Sell(S)3K$3.38$10K52K
Jun 12, 2025Sell(S)11K$3.38$37K196K
Jun 12, 2025Sell(S)19K$3.38$63K336K
Jun 12, 2025Sell(S)7K$3.38$22K119K
Jun 12, 2025Sell(S)22K$3.38$73K387K
Jun 11, 2025Sell(S)338$3.40$1K409K
Jun 11, 2025Sell(S)45$3.40$15355K
Jun 11, 2025Sell(S)171$3.40$581207K
Jun 11, 2025Sell(S)293$3.40$996354K
Jun 11, 2025Sell(S)103$3.40$350125K
Jun 10, 2025Sell(S)5$3.40$17355K
Jun 10, 2025Sell(S)5$3.40$17409K
Jun 10, 2025Sell(S)2$3.40$7125K
Jun 10, 2025Sell(S)3$3.40$10207K
Jun 10, 2025Sell(S)1$3.40$355K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-059091) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML